Crossmark

Pharmacophore-based approach for identifying compounds with myricetin-like pharmacophoric features as potential GSK3β inhibitors in Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1007/s44371-026-00508-9

Published Online: 2026-02-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Roy, Dhritiman https://orcid.org/0000-0001-6225-7029
Kakoti, Bibhuti Bhusan https://orcid.org/0000-0003-4492-9439
Rymbai, Emdormi https://orcid.org/0000-0002-4540-1073
License Information

Text and Data Mining valid from 2026-02-01

Version of Record valid from 2026-02-01
More Information

Article History

Received: 26 June 2025

Accepted: 28 January 2026

First Online: 1 February 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below